Clinical Trial Update: Exploratory Study to Standard Triple Therapy With Tegoprazan(by Dose) in H. Pylori Positive Patients [Phase 2]

View source ↗

Summary

Exploratory Phase 2 trial evaluating standard triple therapy including tegoprazan in Helicobacter pylori–positive patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Tegoprazan (tegoprazan)

Snippet

Sponsor: HK inno.N Corporation | Conditions: Helicobacter Pylori Infection | Phase 2 | Status: UNKNOWN